Global contract research, development and manufacturing services firm Syngene is envisaging an investment of up to ₹788 crore on expansion of its operations in Genome Valley, in a big boost for the well-known life sciences R&D and clean manufacturing cluster near Hyderabad.
It has acquired 17 acres for the new research facilities, primarily laboratories for drug discovery, whose construction is expected to begin in 2024, once necessary statutory approvals are in place. The expanded campus will generate up to 1,000 jobs in science over the next five years, Syngene said after the ground-breaking ceremony on Thursday, in which Industries and IT Minister K.T.Rama Rao and Secretary Jayesh Ranjan, the company’s non-executive chairperson Kiran Mazumdar Shaw, COO Mahesh Bhalgat and others participated.
“Syngene’s expansion is a testament to the tremendous opportunities and support that our State provides. At Genome Valley, we aim to facilitate necessary infrastructure and support systems to enable pioneering lifescience R&D activities. This expansion aligns with our vision to attract and nurture top talent, drive innovation and foster economic development,” the Minister said.
